In addition, compared to ASCs, ASC-EVs cocultured with SSc-like myofibroblasts significantly downregulate myofibroblast markers and inhibit TGF-β stimulation, further underscoring the therapeutic potential of ASC-EVs in SSc [99]. The gene discussed is TGFB1; the disease is systemic sclerosis.